BioXcel Therapeutics, Inc.
BTAI
$1.85
$0.169.47%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 29.85M | 40.39M | 56.27M | 74.14M | 65.22M |
| Total Receivables | 131.00K | 3.00K | 812.00K | 378.00K | 71.00K |
| Inventory | 679.00K | 1.53M | 2.68M | 2.44M | 1.99M |
| Prepaid Expenses | 5.29M | 4.48M | 2.78M | 2.10M | 2.78M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.44M | 1.40M | 1.64M | 1.86M | 2.08M |
| Total Current Assets | 37.39M | 47.79M | 64.18M | 80.92M | 72.14M |
|
|
|||||
| Total Current Assets | 37.39M | 47.79M | 64.18M | 80.92M | 72.14M |
| Net Property, Plant & Equipment | 857.00K | 1.01M | 1.17M | 1.32M | 1.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 87.00K | 87.00K | 87.00K | 87.00K | 87.00K |
| Total Assets | 38.34M | 48.89M | 65.44M | 82.32M | 73.70M |
|
|
|||||
| Total Accounts Payable | 15.99M | 14.89M | 13.26M | 17.22M | 13.65M |
| Total Accrued Expenses | 5.78M | 8.57M | 13.49M | 13.71M | 13.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 374.00K | 368.00K | 361.00K | 353.00K | -- |
| Total Finance Division Other Current Liabilities | 91.00K | 1.73M | 177.00K | 201.00K | 462.00K |
| Total Other Current Liabilities | 91.00K | 1.73M | 177.00K | 201.00K | 462.00K |
| Total Current Liabilities | 22.23M | 25.56M | 27.29M | 31.48M | 27.27M |
|
|
|||||
| Total Current Liabilities | 22.23M | 25.56M | 27.29M | 31.48M | 27.27M |
| Long-Term Debt | 102.51M | 104.44M | 103.01M | 101.63M | 100.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 65.00K | 161.00K | 256.00K | 350.00K | 440.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.63M | 4.37M | 9.19M | 21.22M | 1.91M |
| Total Liabilities | 131.44M | 134.53M | 139.74M | 154.69M | 130.21M |
|
|
|||||
| Common Stock & APIC | 557.10M | 553.71M | 551.39M | 545.03M | 534.09M |
| Retained Earnings | -650.20M | -639.34M | -625.69M | -617.39M | -590.60M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -93.10M | -85.63M | -74.30M | -72.36M | -56.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -93.10M | -85.63M | -74.30M | -72.36M | -56.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -93.10M | -85.63M | -74.30M | -72.36M | -56.51M |
|
|
|||||